ALF

Winners of the American Liver Foundation 2024 Poster Competition Announced

Retrieved on: 
星期四, 五月 9, 2024
Education, Wilfrid Sellars, University, ALF, Learning, Liver disease, Hospital, Montefiore Medical Center, Poster, Communication, NYU Langone Health, Research, Boston Medical Center, American Liver Foundation, Growth, Hepatology, Patient, Fatty liver disease, Associate, Liver cancer, Liver transplantation, Knowledge, Nursing

NEW YORK, May 9, 2024 /PRNewswire/ -- Winners from the American Liver Foundation's 2024 Liver Health Poster Competition were announced today. This competition showcases posters and a brief video created by early career healthcare professionals from across the country on six areas of liver educational focus: disparities in liver disease, fatty liver disease (newly renamed to steatotic liver disease), liver cancer, liver transplantation, pediatric liver disease, and rare liver disease. Competitors are tasked with translating complicated medical information into a poster that can be easily understood by patients or the public.

Key Points: 
  • NEW YORK, May 9, 2024 /PRNewswire/ -- Winners from the American Liver Foundation's 2024 Liver Health Poster Competition were announced today.
  • This competition showcases posters and a brief video created by early career healthcare professionals from across the country on six areas of liver educational focus: disparities in liver disease, fatty liver disease (newly renamed to steatotic liver disease), liver cancer, liver transplantation, pediatric liver disease, and rare liver disease.
  • Winners from the American Liver Foundation's 2024 Liver Health Poster Competition were announced today.
  • The 2024 Liver Health Poster Competition category winners are:
    Eduardo A. Canto, Creighton University School of Medicine, for his presentation on disparities in liver disease .

Concept Schools's 16th annual Art & Language Festival draws in hundreds of people

Retrieved on: 
星期三, 五月 8, 2024
Courage, ALF, Concept Schools, Exhibition, Parent, Student, Emotion, Life, Singing, La Llorona, School, Creativity, Bidi Bidi Bom Bom, Painting, Copernicus Foundation, Entertainment

CHICAGO, May 8, 2024 /PRNewswire/ -- Hundreds of students, teachers and parents made their way across the Midwest to the Copernicus Center on May 4 for the 16th annual Art & Language Festival.

Key Points: 
  • CHICAGO, May 8, 2024 /PRNewswire/ -- Hundreds of students, teachers and parents made their way across the Midwest to the Copernicus Center on May 4 for the 16th annual Art & Language Festival.
  • Schools within Concept Schools's network came together to marvel at the work their students put months of effort into––and it did not disappoint.
  • "It's important for students to have confidence in themselves," Concept Schools President and CEO Sedat Duman said.
  • Concept Schools exists to help students reach their full potential and they are able to develop their communication skills at ALF."

Dwight Capital & Dwight Mortgage Trust Close $152.5MM in Seniors Housing During Q1 2024

Retrieved on: 
星期四, 五月 2, 2024
Commercial Building & Real Estate, Construction & Property, Finance, Banking, Professional Services, Urban Planning, REIT, Residential Building & Real Estate, SNF, ALF, Capital, HUD, DMT, General number field sieve, Acquisition, Financial services

Dwight Capital and its affiliate REIT, Dwight Mortgage Trust (“DMT”), financed $152.5MM in seniors housing during Q1 2024.

Key Points: 
  • Dwight Capital and its affiliate REIT, Dwight Mortgage Trust (“DMT”), financed $152.5MM in seniors housing during Q1 2024.
  • DMT closed a $44MM bridge acquisition loan for a 369-bed SNF in the Southwest U.S.
  • These HUD loans refinanced existing bridge loans provided by Dwight Mortgage Trust in December 2022.
  • Some other notable Q1 2024 transactions:
    $24.6MM bridge acquisition loan for a 369-bed SNF in New Jersey.

CUEN – Cuentas Releases Annual Financial Reports Reflecting Improved Business Transition Results, Revenues and Profitability

Retrieved on: 
星期二, 四月 16, 2024
Sale, Mastercard, ALF, Investment, Nature, Mobile, Republic Bank, Housing, OTC, Management, Fintech, Intangibles, Fiscal year, Partnership, Intelligence, Digital, GPR, Engineering, ESIM, Acquisition, MIAMI, Empathy, Telecommunications, Marketing, Digital divide, Mobile telephony, Cryptocurrency

MIAMI BEACH, FL, April 16, 2024 (GLOBE NEWSWIRE) -- Cuentas, Inc. (OTC: CUEN & CUENW) (“CUEN” or “the Company”), a pioneer driving the seamless integration of fintech, mobile telecommunications, and real estate for the unbanked and underbanked Hispanic demographic, announced today the publication of the company’s FY 2023 financial report on SEC Form 10K. The report reflects the company’s financial results supported by its diversified offerings serving consumers' comprehensive basic needs, from housing to secure communications to innovative financial services. Management comments on the imminent completion of the definitive sale of its Brooksville, Florida property. 

Key Points: 
  • Cuentas strategically aligns its offerings with the needs of its target market, refraining from activation fees and maintaining low monthly charges.
  • The company's approach integrates empathy and affordability, aiming to provide value to its users while ensuring profitability through various revenue channels.
  • Cuentas has fortified its business with a robust mobile service, Cuentas Mobile, supported by a powerful distribution ecosystem, underpinned by a meticulously developed software platform.
  • The Cuentas Platform integrates Cuentas Mobile, the Company’s Mobile Telecommunications solution, with its core financial services offerings to help entire communities enter the modern financial marketplace.

First National Study to Assess the Prevalence of NAFLD to be Conducted by Federal Government

Retrieved on: 
星期四, 四月 25, 2024
Congress, Fatty liver disease, ALF, Language, NAFLD, Liver disease, Risk, Hispanic, AHRQ, Overweight, Diabetes, FAST, Partnership, Agency, Research, American Liver Foundation, Disease, Obesity, Labour, NASH, Patient, Liver failure, Society, Metabolic syndrome, American Society of Transplantation, Liver transplantation, Prevalence, Dietary supplement

NEW YORK, April 25, 2024 /PRNewswire/ -- A first-ever national study to assess the prevalence of nonalcoholic fatty liver disease (NAFLD)* will be conducted by the Agency for Healthcare Research and Quality (AHRQ)**, in collaboration with other federal agency stakeholders, to evaluate the prevalence, diagnoses, treatments and complications associated with NAFLD.

Key Points: 
  • NEW YORK, April 25, 2024 /PRNewswire/ -- A first-ever national study to assess the prevalence of nonalcoholic fatty liver disease (NAFLD)* will be conducted by the Agency for Healthcare Research and Quality (AHRQ)**, in collaboration with other federal agency stakeholders, to evaluate the prevalence, diagnoses, treatments and complications associated with NAFLD.
  • New national study to assess prevalence of NAFLD to be conducted, ALF grateful to Congress and advocates.
  • "We are so grateful to Senator Bill Cassidy (R-LA) for his leadership in championing this effort on Capitol Hill.
  • In an online liver health quiz to assess risk factors, 93% of respondents received a positive result for being at risk for NAFLD.

Boston Marathon Runners Go Again to Fight Liver Disease

Retrieved on: 
星期五, 四月 12, 2024
Congenital hepatic fibrosis, ALF, Liver disease, Primary sclerosing cholangitis, Health, Partnership, American Liver Foundation, History, Disease, Boston Marathon, Boston Athletic Association, Memory, Kostecki, Liver cancer, Running

NEW YORK, April 12, 2024 /PRNewswire/ -- The American Liver Foundation (ALF) is proud to once again be a member of the Boston Marathon Official Charity Program for the 2024 Boston Marathon®, which takes place on Monday, April 15, 2024.

Key Points: 
  • 128th Annual Boston Marathon is Monday, April 15th
    NEW YORK, April 12, 2024 /PRNewswire/ -- The American Liver Foundation (ALF) is proud to once again be a member of the Boston Marathon Official Charity Program for the 2024 Boston Marathon®, which takes place on Monday, April 15, 2024.
  • American Liver Foundation (ALF) runners participate in the 2024 Boston Marathon® to raise awareness of liver disease!
  • Since 1988, the American Liver Foundation Marathon Team has made a dramatic impact on the American Liver Foundation's mission.
  • The American Liver Foundation team is made up of novice to experienced runners, most of whom have a connection to liver disease.

Liver Patients, Families, and Medical Professionals Walk to End Liver Disease

Retrieved on: 
星期四, 四月 11, 2024
Biliary atresia, ALF, News, Patient, Liver, Twin, Liver disease, Life, American Liver Foundation, Dietary supplement

NEW YORK, April 11, 2024 /PRNewswire/ -- The American Liver Foundation (ALF) has begun hosting its annual Liver Life Walk for 2024 at 20 in-person locations across the country. Liver Life Walk raises funds and awareness for liver disease and helps create life-long connections and networks of support between patients, families and all those affected by liver disease.

Key Points: 
  • Liver Life Walk raises funds and awareness for liver disease and helps create life-long connections and networks of support between patients, families and all those affected by liver disease.
  • American Liver Foundation has begun hosting the 2024 Liver Life Walk at 20 in-person locations across the country.
    "
  • Liver Life Walk has been a signature event of American Liver Foundation since 1999," said Lorraine Stiehl, Chief Executive Officer of ALF.
  • "Funds raised through the Liver Life Walk empowers ALF to continue providing valuable resources to liver patients and their families, fund critical liver disease research, and advance public health education and improved patient treatment and coverage."

World-renowned Chefs Gather to Raise Awareness and Funds for Liver Disease

Retrieved on: 
星期三, 四月 3, 2024
Local, Education, Wrigley Mansion, ALF, American Liver Foundation, Research, Iron Chef, Iron Chef America, Restaurant, Heart, Table, Liver disease

NEW YORK, April 3, 2024 /PRNewswire/ -- The American Liver Foundation (ALF) has teamed up with world-renowned culinary expert Chef Christopher Gross and Celebrity Chef Mark Tarbell from Iron Chef for FLAVORS, a national culinary event to be held in Phoenix, Arizona on May 22, 2024.

Key Points: 
  • ALF and world-renowned culinary expert Chef Christopher Gross team up for FLAVORS, a national culinary event on May 22.
  • "ALF is delighted for the return of FLAVORS with our founder, Chef Christopher," said Lorraine Stiehl, Chief Executive Officer, American Liver Foundation.
  • "The generosity of these chefs and those philanthropists attending help us continue to provide life-saving resources, support, research and education for the nearly 100 million of Americans affected by liver disease."
  • Chef Christopher will be joined by seven other local chefs, including Mark Tarbell, winner of 2007 "Iron Chef America".

American Liver Foundation Celebrates Donate Life Month with New Patient Resources, Programs and Support

Retrieved on: 
星期一, 四月 1, 2024
American Liver Foundation, Journey, Celebration, Liver disease, Environment, Caregiver, Patient, Social media, News, Liver transplantation, MD, ALF, North Shore University Hospital, Liver, Partner, Fatigue, Sadness, Dentistry

April is Donate Life Month and American Liver Foundation (ALF) has new patient resources, programs and support available to all liver transplant patients and the caregivers supporting them.

Key Points: 
  • April is Donate Life Month and American Liver Foundation (ALF) has new patient resources, programs and support available to all liver transplant patients and the caregivers supporting them.
  • "An informed patient is critically important to making the best decisions about care and ensuring the most favorable outcomes," said Lorraine Stiehl, Chief Executive Officer, American Liver Foundation and caregiver to a transplant recipient.
  • Liver patients, families and loved ones are invited to celebrate the gift of life and the importance of liver transplantation.
  • Throughout Donate Life Month ALF encourages patients, caregivers and organ donors to be part of the national conversation!

American Liver Foundation Statement on FDA Approval of Resmetirom

Retrieved on: 
星期四, 三月 14, 2024
HCC, Liver failure, American Liver Foundation, Fatty liver disease, Liver disease, Disease, Caregiver, Risk, Cirrhosis, Inflammation, Chairperson, Patient, Life, Liver transplantation, Hope, Doctor of Philosophy, MASH, MD, ALF, Pharmacotherapy, Fibrosis, NASH, Hepatology, Hepatocellular carcinoma, NAFLD, FDA, Liver, Food, Pharmaceutical industry

FAIRFIELD, N.J., March 14, 2024 /PRNewswire/ -- Today, the Food and Drug Administration (FDA) granted accelerated approval of a first of its kind drug therapy, resmetirom, for the treatment of nonalcoholic steatohepatitis (NASH) in patients who have progressed to fibrosis. NASH, now called metabolic dysfunction-associated steatohepatitis or MASH, is a dangerously progressive form of nonalcoholic fatty liver disease* (NAFLD) and causes inflammation in the liver and liver damage.

Key Points: 
  • NASH, now called metabolic dysfunction-associated steatohepatitis or MASH, is a dangerously progressive form of nonalcoholic fatty liver disease * (NAFLD) and causes inflammation in the liver and liver damage.
  • "American Liver Foundation applauds the FDA approval of the groundbreaking new drug therapy treatment, resmetirom, for patients with NASH who have progressed to fibrosis," said Lorraine Stiehl , Chief Executive Officer, American Liver Foundation.
  • American Liver Foundation offers many free resources to patients and families affected by liver disease.
  • *Note: The nomenclature for NAFLD and NASH recently changed to metabolic dysfunction-associated liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) respectively.